Literature DB >> 3444797

The incidence and causes of hypercalcaemia.

D M Dent1, J L Miller, L Klaff, J Barron.   

Abstract

A prospective screen for hypercalcaemia in 58,053 hospital in-patients was conducted over 12 months. The incidence of hypercalcaemia was 0.6%, being transient in 19.2% of patients and sustained in the remainder. The most common causes in the sustained group were malignancy (45%) and primary hyperparathyroidism (16.5%). The incidence of primary hyperparathyroidism was 78/100,000 hospital in-patients, and its discovery was directly attributable to the survey in over half the cases.

Entities:  

Mesh:

Year:  1987        PMID: 3444797      PMCID: PMC2428526          DOI: 10.1136/pgmj.63.743.745

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  21 in total

1.  The clinical value of routine serum calcium analysis.

Authors:  C E BOONSTRA; C E JACKSON
Journal:  Ann Intern Med       Date:  1962-12       Impact factor: 25.391

2.  Diagnosis of primary hyperparathyroidism. Clinical and laboratory aspects.

Authors:  F R KEATING
Journal:  JAMA       Date:  1961-11-11       Impact factor: 56.272

3.  Familial hyperparathyroidism.

Authors:  T Christensson
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

4.  Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening.

Authors:  G Stenström; P A Heedman
Journal:  Acta Med Scand       Date:  1974-06

5.  Clinical findings in patients with hypercalcaemia. A preliminary investigation based on biochemical screening.

Authors:  P A Heedman; G Stenström
Journal:  Acta Med Scand       Date:  1973-03

6.  Primary hyperparathyroidism: changing clinical, surgical and pathologic aspects.

Authors:  R C Haff; W C Black; W F Ballinger
Journal:  Ann Surg       Date:  1970-01       Impact factor: 12.969

7.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

8.  [Hypercalcemia in hospitalized patients. Diagnostic and prognostic aspects].

Authors:  E Burkhardt; H J Kistler
Journal:  Schweiz Med Wochenschr       Date:  1981-12-19

9.  Incidence of hypercalcaemia and primary hyperparathyroidism in relation to the biochemical profile.

Authors:  J S Harrop; J E Bailey; J S Woodhead
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

10.  Hypercalcaemia--a hospital survey.

Authors:  R A Fisken; D A Heath; A M Bold
Journal:  Q J Med       Date:  1980
View more
  9 in total

1.  Thiazide therapy and severe hypercalcemia in a patient with hyperparathyroidism.

Authors:  P Strong; S Jewell; J Rinker; D Hoch; L Crapo
Journal:  West J Med       Date:  1991-03

Review 2.  [Metabolic disorders as paraneoplastic syndromes].

Authors:  S Krug; P Michl
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

Review 3.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

4.  The changing profile of hypercalcemia in a tertiary care setting in North India: an 18-month retrospective study.

Authors:  Mohammad Shafi Kuchay; Parjeet Kaur; Sunil Kumar Mishra; Ambrish Mithal
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

Review 5.  Hypercalcaemia - presentation and management .

Authors:  Jeremy J O Turner
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

6.  Primary hyperparathyroidism in Austria: results of an 8-year prospective study.

Authors:  B Niederle; L Stamm; F Längle; E Schubert; W Woloszczuk; R Prager
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

Review 7.  Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.

Authors:  Ana L Huerta-Alardín; Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2004-10-20       Impact factor: 9.097

8.  Hypercalcemia associated with dysgerminoma and elevation of calcitriol: A case report and review of the literature.

Authors:  Natsuko Hara; Hirotsugu Suwanai; Hironori Abe; Fumiyoshi Yakou; Takuya Ishikawa; Munehiro Urayama; Takeshi Nagai; Toshitaka Nagao; Jumpei Shikuma; Takashi Miwa; Ryo Suzuki; Masato Odawara
Journal:  SAGE Open Med Case Rep       Date:  2022-01-18

9.  Frequency of Parathyroid Hormone Assessment in the Evaluation of Hypercalcemia. A Comparison Between Patients With and Without a History of Malignancy in a 20-year Dataset of 20,954 Patients.

Authors:  Michael T Sheehan; Ya-Huei Li; Suhail A Doi; Adedayo A Onitilo
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2021-11-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.